Ovarian Cancer Trial, Recruiting NCT01000259 Sponsor: Gynecologic Oncology Group Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT01000259
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stage III or IV ovarian epithelial cancer (a specific type of ovarian cancer at an advanced stage) and were previously enrolled in certain Gynecologic Oncology Group (GOG) studies involving platinum and taxol chemotherapy treatments (confirm with trial site for which specific studies apply)
  • People for whom preserved tissue samples from their primary surgery are available and stored in a specific medical format (called paraffin-embedded tissue)
  • People who previously had surgery to remove as much cancer as possible, whether or not all of the cancer could be removed
  • People for whom detailed health and medical history records, including key cancer-related factors and follow-up health information, were collected during prior studies
  • People whose cancer was measurable or detectable at the time of their prior treatment

Who may not be able to join:

  • No specific exclusion criteria were listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gynecologic Oncology Group
Registry
ClinicalTrials.gov
Start date
1 September 2004
Est. completion
1 January 2100

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Overall survival curves; Progression-free survival curves

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov